Live Breaking News & Updates on Hcw biologics

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Approximately 0.1% of the shares of the company are […]

Biologics-company-profile , Biologics-inc , Nasdaq , Hcw-biologics-inc , Blackrock-inc , Avantax-planning-partners-inc , Hightower-advisors , Vanguard-group-inc , Get-free-report , Planning-partners , Tower-advisors

Rebecca Byam Bought 122% More Shares In HCW Biologics

HCW Biologics Inc. ( NASDAQ:HCWB ) shareholders (or potential shareholders) will be happy to see that the Chief.

Hcw-biologics , Nsider-transactions , Rebecca-byam , Hcw-biologics-inc , Hare-price , Nsider-ownership ,

Several Insiders Invested In HCW Biologics Flagging Positive News

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying.

Boast-high-insider , Insider-transactions , Hcw-biologics , Nsider-ownership , Hare-price , Ompany ,

HCW Biologics Inc. (NASDAQ:HCWB) Sees Large Drop in Short Interest

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 21,400 shares, a decrease of 14.4% from the August 15th total of 25,000 shares. Currently, 0.1% of the company’s stock are short sold. […]

Blackrock-inc , Hcw-biologics-inc , Vanguard-group-inc , Hightower-advisors , Biologics-inc , Nasdaq , Get-free-report , Tower-advisors , Hcw-biologics , Nasdaq-hcwb , Hcwb

Insider Stock Buying Reaches US$845k On HCW Biologics

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying.

Insiders-bought-stock , Insider-transactions , Hcw-biologics , Nsider-ownership , Cw-biologics-insiders , Nsider-transaction ,

Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Drops By 13.4%

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 23,200 shares, a drop of 13.4% from the July 15th total of 26,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]

Rebecca-byam , Biologics-company-profile , Nasdaq , Biologics-inc , Vanguard-group-inc , Ef-hutton-acquisition-co , Hcw-biologics-inc , Blackrock-inc , Hightower-advisors , Securities-exchange-commission , Get-free-report , Stock-down

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 86.9% in June

HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 24,300 shares, a growth of 86.9% from the May 31st total of 13,000 shares. Currently, 0.1% of the company’s shares are short sold. Based […]

Rebecca-byam , Nasdaq , Ef-hutton-acquisition-co , Blackrock-inc , Hcw-biologics-inc , Biologics-inc , Vanguard-group-inc , Biologics-company-profile , Hightower-advisors , Free-report , Stock-down , Tower-advisors

HCW Biologics Inc. (NASDAQ:HCWB) Sees Significant Increase in Short Interest

HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 24,300 shares, an increase of 86.9% from the May 31st total of 13,000 shares. Based on an average daily trading volume, of 19,500 shares, […]

Rebecca-byam , Nasdaq , Vanguard-group-inc , Blackrock-inc , Ef-hutton-acquisition-co , Hightower-advisors , Biologics-inc , Hcw-biologics-inc , Free-report , Tower-advisors , Hcw-biologics , Nasdaq-hcwb

Reviewing HCW Biologics (NASDAQ:HCWB) & GRI Bio (NASDAQ:GRI)

HCW Biologics (NASDAQ:HCWB – Free Report) and GRI Bio (NASDAQ:GRI – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Insider & Institutional Ownership 2.4% of HCW Biologics shares […]

La-jolla , California , United-states , Florida , Bio-inc , Biologics-inc , Glycoregimmune-inc , Free-report , Hcw-biologics , Nasdaq-hcwb , Hcwb